Weekly Tech+Bio Highlights #66: AI Antibody Startup Hits Unicorn Status

Merck & Nvidia Debut Open-Source Drug Model; Microsoft’s Spatial Proteomics, & First Non-Profit Gets FDA Approval for Gene Therapy

Hi! This is BiopharmaTrend’s weekly newsletter, Where Tech Meets Bio, where we explore technologies, breakthroughs, and cutting-edge companies.

If this newsletter is in your inbox, it’s because you subscribed, or someone thought you might enjoy it. In either case, you can subscribe directly by clicking this button: